NARACHI MICHAEL Insider Trading
Get the latest insider transactions of NARACHI MICHAEL. NARACHI MICHAEL is Director in AMAG PHARMACEUTICALS INC. ($AVM) and Director in Eiger BioPharmaceuticals, Inc. ($EIGR) and CEO & President in Orexigen Therapeutics, Inc. ($OREX) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE). Discover the current value of NARACHI MICHAEL shares.
Address: C/O ADVANCED MAGNETICS, INC. 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE 02140MA
NARACHI MICHAEL is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
AVM | AMAG PHARMACEUTICALS, INC. | Director | 0 | 0.00 |
RARE | Ultragenyx Pharmaceutical Inc. | Director | 14,445 | 1,053,184.95 |
EIGR | Eiger BioPharmaceuticals, Inc. | Director | 0 | 0.00 |
OREX | Orexigen Therapeutics, Inc. | CEO & President | 8,356 | 38,270.48 |
Insider Trading Transactions of NARACHI MICHAEL
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Jun 28 2021 | RARE | Ultragenyx Pharmaceutical ... | NARACHI MICHAEL | Director | Buy | 0.00 | 2,145 | 0 | 14,445 |
Jun 28 2021 | RARE | Ultragenyx Pharmaceutical ... | NARACHI MICHAEL | Director | Option Exercise | 93.20 | 4,125 | 384,450 | 4,125 |
Jun 30 2020 | RARE | Ultragenyx Pharmaceutical ... | NARACHI MICHAEL | Director | Buy | 0.00 | 2,550 | 0 | 12,300 |
Jun 30 2020 | RARE | Ultragenyx Pharmaceutical ... | NARACHI MICHAEL | Director | Option Exercise | 76.58 | 4,250 | 325,465 | 4,250 |
Jun 13 2019 | RARE | Ultragenyx Pharmaceutical ... | NARACHI MICHAEL | Director | Buy | 0.00 | 3,000 | 0 | 9,750 |
Jun 13 2019 | RARE | Ultragenyx Pharmaceutical ... | NARACHI MICHAEL | Director | Option Exercise | 58.74 | 5,000 | 293,700 | 5,000 |
Jun 20 2018 | RARE | Ultragenyx Pharmaceutical ... | NARACHI MICHAEL | Director | Buy | 0.00 | 3,000 | 0 | 6,750 |
Jun 20 2018 | RARE | Ultragenyx Pharmaceutical ... | NARACHI MICHAEL | Director | Option Exercise | 80.69 | 5,000 | 403,450 | 5,000 |
Oct 17 2017 | OREX | Orexigen Therapeutics, In ... | NARACHI MICHAEL | CEO & President | Option Exercise | 0.00 | 252,000 | 0 | 252,000 |
Jun 22 2017 | RARE | Ultragenyx Pharmaceutical ... | NARACHI MICHAEL | Director | Buy | 0.00 | 1,875 | 0 | 3,750 |
Jun 22 2017 | RARE | Ultragenyx Pharmaceutical ... | NARACHI MICHAEL | Director | Option Exercise | 65.66 | 3,750 | 246,225 | 3,750 |
Jun 02 2017 | OREX | Orexigen Therapeutics, In ... | NARACHI MICHAEL | CEO & President | Buy | 1.55 | 626 | 970 | 8,356 |
Feb 07 2017 | OREX | Orexigen Therapeutics, In ... | NARACHI MICHAEL | CEO & President | Option Exercise | 4.10 | 315,000 | 1,291,500 | 315,000 |
Feb 07 2017 | OREX | Orexigen Therapeutics, In ... | NARACHI MICHAEL | CEO & President | Option Exercise | 15.00 | 157,500 | 2,362,500 | 157,500 |
Dec 02 2016 | OREX | Orexigen Therapeutics, In ... | NARACHI MICHAEL | CEO & President | Buy | 1.67 | 802 | 1,339 | 6,312 |
Jul 14 2016 | OREX | Orexigen Therapeutics, In ... | NARACHI MICHAEL | CEO & President | Option Exercise | 4.02 | 525,000 | 2,110,500 | 525,000 |
Jul 14 2016 | OREX | Orexigen Therapeutics, In ... | NARACHI MICHAEL | CEO & President | Option Exercise | 4.02 | 105,000 | 422,100 | 105,000 |
Jul 14 2016 | OREX | Orexigen Therapeutics, In ... | NARACHI MICHAEL | CEO & President | Option Exercise | 15.00 | 315,000 | 4,725,000 | 315,000 |
Jul 14 2016 | OREX | Orexigen Therapeutics, In ... | NARACHI MICHAEL | CEO & President | Option Exercise | 15.00 | 63,000 | 945,000 | 63,000 |
Jun 14 2016 | RARE | Ultragenyx Pharmaceutical ... | NARACHI MICHAEL | Buy | 0.00 | 1,875 | 0 | 1,875 | |
Jun 14 2016 | RARE | Ultragenyx Pharmaceutical ... | NARACHI MICHAEL | Option Exercise | 65.85 | 3,750 | 246,938 | 3,750 | |
Jun 02 2016 | OREX | Orexigen Therapeutics, In ... | NARACHI MICHAEL | CEO & President | Buy | 0.34 | 8,777 | 2,984 | 69,285 |
Feb 04 2016 | OREX | Orexigen Therapeutics, In ... | NARACHI MICHAEL | CEO & President | Buy | 4.17 | 721 | 3,007 | 58,747 |
Feb 04 2016 | OREX | Orexigen Therapeutics, In ... | NARACHI MICHAEL | CEO & President | Buy | 2.03 | 1,761 | 3,575 | 60,508 |
Feb 04 2016 | OREX | Orexigen Therapeutics, In ... | NARACHI MICHAEL | CEO & President | Option Exercise | 1.78 | 700,000 | 1,246,000 | 700,000 |
Feb 04 2016 | OREX | Orexigen Therapeutics, In ... | NARACHI MICHAEL | CEO & President | Option Exercise | 0.00 | 800,000 | 0 | 800,000 |
Jun 22 2015 | RARE | Ultragenyx Pharmaceutical ... | NARACHI MICHAEL | Option Exercise | 97.85 | 7,500 | 733,875 | 7,500 | |
Jun 05 2015 | EIGR | Eiger BioPharmaceuticals, ... | NARACHI MICHAEL | Director | Option Exercise | 2.16 | 10,000 | 21,600 | 50,000 |
Feb 24 2015 | RARE | Ultragenyx Pharmaceutical ... | NARACHI MICHAEL | Director | Option Exercise | 55.57 | 17,500 | 972,475 | 17,500 |
Nov 09 2006 | AVM | AMAG PHARMACEUTICALS INC. | NARACHI MICHAEL | Director | Option Exercise | 41.16 | 8,801 | 362,249 | 8,801 |